EUVIMEDEUVIMED entdecken
Crossref

Toward more accurate preclinical glioblastoma modeling: Reverse translation of clinical standard of care in a glioblastoma mouse model

Aaron Ziani-Zeryouh, Roxanne Wouters, Gitte Thirion, Katja Vandenbrande, Ann Vankerckhoven, Yani Berckmans, Sien Bevers, Jelle Verbeeck, Kim De Keersmaecker, An Coosemans, Matteo Riva

Methods in Cell Biology · 2024

DOI: 10.1016/bs.mcb.2023.07.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Methods in Cell Biology, 2024. Verfasst von Aaron Ziani-Zeryouh und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Tumor Immunology and Immunotherapy, Department of Oncology, Leuven Cancer Institute, KU Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms. Die Arbeit nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaBrain NeoplasmsAnimalsMiceHumansTemozolomideStandard of Care

Stichwörter der Autor:innen

CT-2ACombination therapiesGlioblastomaHGGMouse modelPreclinicalRadiotherapySurgeryTemozolomide

Substanzen

Temozolomide

Autor:innen und Institutionen

  • Laboratory of Tumor Immunology and Immunotherapy, Department of Oncology, Leuven Cancer Institute, KU Leuven, Leuven, Belgium.
  • Laboratory of Tumor Immunology and Immunotherapy, Department of Oncology, Leuven Cancer Institute, KU Leuven, Leuven, Belgium; Oncoinvent, A.S., Oslo, Norway.
  • Laboratory for Disease Mechanisms in Cancer, Department of Oncology, Leuven Cancer Institute, KU Leuven, Leuven, Belgium.
  • Laboratory of Tumor Immunology and Immunotherapy, Department of Oncology, Leuven Cancer Institute, KU Leuven, Leuven, Belgium. Electronic address: an.coosemans@kuleuven.be.
  • Laboratory of Tumor Immunology and Immunotherapy, Department of Oncology, Leuven Cancer Institute, KU Leuven, Leuven, Belgium; Department of Neurosurgery, Mont-Godinne Hospital, UCL Namur, Yvoir, Belgium.

Zitieren

APA

Ziani-Zeryouh, A., Wouters, R., Thirion, G., Vandenbrande, K., Vankerckhoven, A., Berckmans, Y., Bevers, S., Verbeeck, J., De Keersmaecker, K., Coosemans, A., & Riva, M. (2024). Toward more accurate preclinical glioblastoma modeling: Reverse translation of clinical standard of care in a glioblastoma mouse model. Methods in Cell Biology. https://doi.org/10.1016/bs.mcb.2023.07.003

Vancouver

Ziani-Zeryouh A, Wouters R, Thirion G, Vandenbrande K, Vankerckhoven A, Berckmans Y, et al. Toward more accurate preclinical glioblastoma modeling: Reverse translation of clinical standard of care in a glioblastoma mouse model. Methods in Cell Biology. 2024. doi:10.1016/bs.mcb.2023.07.003

BibTeX
@article{ZianiZeryouh2024,
  author = {Ziani-Zeryouh, Aaron and Wouters, Roxanne and Thirion, Gitte and Vandenbrande, Katja and Vankerckhoven, Ann and Berckmans, Yani and Bevers, Sien and Verbeeck, Jelle and De Keersmaecker, Kim and Coosemans, An and Riva, Matteo},
  title = {Toward more accurate preclinical glioblastoma modeling: Reverse translation of clinical standard of care in a glioblastoma mouse model},
  journal = {Methods in Cell Biology},
  year = {2024},
  doi = {10.1016/bs.mcb.2023.07.003}
}
Kostenlos starten →